Human central nervous system primitive neuroectodermal tumor expressing nerve growth factor receptors: CHP707M
David L. Baker(Howard Hughes Medical Institute), David Pleasure(California Institute for Regenerative Medicine), Jaclyn A. Biegel(Children's Hospital of Philadelphia), Barbara Kreider(Children's Hospital of Philadelphia), Marge Williams(Children's Hospital of Philadelphia), Margaret Tartaglione(Children's Hospital of Philadelphia), Patrizia Lo Presti(Children's Hospital of Philadelphia), Usha R. Reddy(University of Pennsylvania), Gita Venkatakrishnan(University of Pennsylvania), Alonzo H. Ross(Worcester Polytechnic Institute), Jie Chen(Second People’s Hospital of Yibin), Audrey E. Evans(Purdue University West Lafayette), B S Emanuel(Children's Hospital of Philadelphia), Mattie Hardy(Children's Hospital of Philadelphia), Samuel J. Pleasure(University of California, San Francisco), Amit R. Roy, John Q. Trojanowski(University of Pennsylvania)
Cited by 27
Related Papers
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k